Protective effect of green tea (Camellia sinensis) against kidney diseases

Vol 1, 2023 - 163233
Oral (On site Format)
Favorite this paper
How to cite this paper?
Abstract

Introducion: Kidney diseases are a global health problem, and their frequency is continuously increasing. Available treatments provide limited kidney protection. The protective effect of the green tea polyphenol epigallocatechin-3-gallate (EGCG) in several diseases has been extensively investigated. Experimental and clinical studies have shown that the antioxidant, anti-inflammatory, and anti-apoptotic properties of EGCG are promising for the treatment and/or prevention of kidney diseases. Objetive: to review the literature on the protective effect of green tea (Camellia sinensis) in kidney diseases. Methods: This review assessed experimental and clinical trials focused on the potential impact of green tea (Camellia sinensis) on its therapeutic efficacy in the treatment of kidney diseases in studies published between 2012 and 2021 in English and indexed in the PubMed and MEDLINE databases. Results: This review analyzed the available evidence on the effects and the likely protective mechanisms of action of EGCG in a broad spectrum of kidney diseases, including acute kidney injury, drug-induced nephrotoxicity, kidney stone disease, diabetic nephropathy, chronic kidney disease, and kidney fibrosis. Conclusion: This review highlights the beneficial role of EGCG as a potent renoprotector through underlying molecular mechanisms, mainly by inhibiting oxidative stress (Nrf2–Keap1 pathway) and inflammation (NF-κB pathway). These data reinforce the potential of EGCG for the treatment and/or prevention of kidney diseases.

Share your ideas or questions with the authors!

Did you know that the greatest stimulus in scientific and cultural development is curiosity? Leave your questions or suggestions to the author!

Sign in to interact

Have a question or suggestion? Share your feedback with the authors!

Institutions
  • 1 Centro Universitário Padre Albino (UNIFIPA)
  • 2 Universidade de São Paulo - USP
Track
  • 1. Management of diseases and immune response: inflammatory, infectious, non-infectious, autoimmune and lifestyle diseases
Keywords
epigallocatechin-3-gallate; acute kidney injury; Chronic Kidney Disease; kidney stones; diabetic nephropathy